MYC and pancreatic neoplasm: On the other hand, lnc00261 is downregulated in pancreatic cancer and can inhibit cancer progression [69, 70], and methylation-mediated lnc00261 can participate in regulating pancreatic cancer by epigenetically inhibiting c-Myc transcription to suppress pancreatic cancer malignant progression [71].